Aerosol therapy by pressured metered-dose inhaler-spacer in sleeping young children: to do or not to do?
Aerosol administration by means of pMDI-spacer during sleep offers no advantage and is not a feasible treatment option in most young children.
Normalization of ALT at 8 wk may predict viral response during peginterferon-ribavirin treatment in genotype-1 CHC patients especially without RVR.